Status:
TERMINATED
Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)
Lead Sponsor:
Seoul National University Hospital
Conditions:
Very Low Birth Weight Infant
Ureaplasma/Mycoplasma Positive
Eligibility:
All Genders
Up to 1 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to investigate the pharmacokinetics of clarithromycin which is used for premature infants with ureaplasma.
Eligibility Criteria
Inclusion
- birthweight \< 1500gm or GA \< 32 weeks
- transtracheal aspirate/gastric juice ; ureaplasma/mycoplasma(+)
Exclusion
- sepsis, hypotension, shock
- major congenital anomaly
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01851954
Start Date
February 1 2013
End Date
April 1 2014
Last Update
November 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Children's Hospital
Seoul, South Korea